Relationship between Antibody Levels and SARS-Cov-2 Reinfection
- PMID: 34921027
Relationship between Antibody Levels and SARS-Cov-2 Reinfection
Abstract
Objective: In this period when mutant strains are increasing all over the world, studies on how much humoral immunity will protect against the Severe Acute Respiratory Syndrome 2 (SARS-CoV-2) are quite limited. The aim of our study is to investigate the positivity and antibody levels of the COVID-19 reverse transcription polymerase chain reaction (RT-PCR) test, the frequency of SARS-CoV-2 re-infection, and the protective antibody level against re-infection.
Methods: Patients who were positive for COVID-19 IgG antibody between 1 July and 31 August were included in our study. The COVID-19 RT-PCR test positivity, age, gender and comorbidities of these patients were recorded before this date. The COVID-19 RT-PCR test positivity of these patients was followed from the National COVID-19 Database between September 1, 2020 and February 28, 2021.
Results: 1665 patients (female: male 683: 982, mean age 40.6±13.4 years). Among all patients, 14 patients had reinfection and the frequency of reinfection was 0.8%. It was observed that the frequency of reinfection was more frequent in patients with PCR negative (p<0.001). The IgG cut-off value causing reinfection was found to be 11.9 (AUC: 0.844, 79.2% sensitivity, 78.6% specificity) (p<0.001).
Conclusion: Humoral antibodies against SARS-CoV-2 were protective against COVID-19 reinfection, 0.8% of the patients had reinfection and the resultant reinfection was mostly seen in PCR negative patients who were asymptomatic.
Keywords: COVID-19; COVID-19 reinfection; Immunity; SARS-CoV-2 antibody.
© 2021 by the Association of Clinical Scientists, Inc.
Similar articles
-
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.J Intern Med. 2022 Jan;291(1):72-80. doi: 10.1111/joim.13387. Epub 2021 Sep 27. J Intern Med. 2022. PMID: 34459525 Free PMC article.
-
Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies.Ultrasound Obstet Gynecol. 2021 Jun;57(6):974-978. doi: 10.1002/uog.23639. Ultrasound Obstet Gynecol. 2021. PMID: 33798280 Free PMC article.
-
Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection.J Adv Res. 2021 Jul;31:49-60. doi: 10.1016/j.jare.2020.12.013. Epub 2021 Jan 5. J Adv Res. 2021. PMID: 33520309 Free PMC article. Review.
-
Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study.Front Immunol. 2021 Sep 3;12:705441. doi: 10.3389/fimmu.2021.705441. eCollection 2021. Front Immunol. 2021. PMID: 34539635 Free PMC article.
-
Differentials of SARS-CoV-2 Viral RNA Re-positivity in Discharged COVID-19 Patients.AIDS Rev. 2021 Jun 3;23(3):153-163. doi: 10.24875/AIDSRev.21000023. AIDS Rev. 2021. PMID: 34082440 Review.
Cited by
-
Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccine.Mult Scler Relat Disord. 2022 Jul;63:103863. doi: 10.1016/j.msard.2022.103863. Epub 2022 May 10. Mult Scler Relat Disord. 2022. PMID: 35667316 Free PMC article.
-
Anti-SARS-CoV-2 Antibody Response Among Spectators of Amir Cup 2020 With a History of Recovery From COVID-19 in Qatar: A Historic Cohort Study.Cureus. 2024 Feb 18;16(2):e54406. doi: 10.7759/cureus.54406. eCollection 2024 Feb. Cureus. 2024. PMID: 38505461 Free PMC article.
-
The serological IgG and neutralizing antibody of SARS-CoV-2 omicron variant reinfection in Jiangsu Province, China.Front Public Health. 2024 May 30;12:1364048. doi: 10.3389/fpubh.2024.1364048. eCollection 2024. Front Public Health. 2024. PMID: 38873290 Free PMC article.
-
Incidence and outcome of SARS-CoV-2 reinfection in the pre-Omicron era: A global systematic review and meta-analysis.J Glob Health. 2023 Nov 24;13:06051. doi: 10.7189/jogh.13.06051. J Glob Health. 2023. PMID: 37994839 Free PMC article.
-
Protection afforded by post-infection SARS-CoV-2 vaccine doses: A cohort study in Shanghai.Elife. 2025 Feb 17;13:RP94990. doi: 10.7554/eLife.94990. Elife. 2025. PMID: 39960759 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous